Tweet
Webinar:
How to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants
In this webinar, whole exome sequencing data of tumor tissue and cell-free DNA derived from two cancer patients will be used to demonstrate how non-invasive liquid biopsies from the blood have the potential to aid in precision medicine. Using Partek® Flow® software, a powerful and easy-to-use bioinformatics tool, we will analyze raw sequence data from individuals with metastatic sarcoma and metastatic breast cancer to identify clinically actionable variants.
You will learn how to:
Live Sessions Offered:
REGISTER NOW
How to Analyze Cell-Free DNA Sequencing Data from Cancer Patients to Identify Clinically Actionable Variants
In this webinar, whole exome sequencing data of tumor tissue and cell-free DNA derived from two cancer patients will be used to demonstrate how non-invasive liquid biopsies from the blood have the potential to aid in precision medicine. Using Partek® Flow® software, a powerful and easy-to-use bioinformatics tool, we will analyze raw sequence data from individuals with metastatic sarcoma and metastatic breast cancer to identify clinically actionable variants.
You will learn how to:
- Align and filter whole exome sequencing data
- Detect variants from tumor and cell-free DNA
- Perform annotation and filtering to prioritize variants
Live Sessions Offered:
- September 27, 2017 at 10am SGT (Singapore)
- September 28, 2017 at 2pm GMT (London)
- September 28, 2017 at 2pm EDT (Boston)
REGISTER NOW